Klebsiella pneumoniae resistant to third-generation cephalosporins in five African and two Vietnamese major towns: Multiclonal population structure with two major international clonal groups, CG15 and CG258

Clinical Microbiology and Infection

Volumn 19, Issue 4, 2013, Pages 349-355

  Breurec, S ^a   Guessennd, N ^b   Timinouni, M ^c   Le, T A H ^d   Cao, V ^e   Ngandjio, A ^f   Randrianirina, F ^g   Thiberge, J M ^h   Kinana, A ^a   Dufougeray, A ^a   Perrier Gros Claude, J D ^c   Boisier, P ^f   Garin, B ^a,g   Brisse, S ^h  

^a INSTITUT PASTEUR DE DAKAR   (Senegal)

^b INSTITUT PASTEUR DE CÔTE D'IVOIRE   (Côte d’Ivoire)

^c Institut Pasteur du Maroc   (Morocco)

^d Inst Natl Hyg et d'Epidemiologie   (Viet Nam)

^e PASTEUR INSTITUTE   (Viet Nam)

^f CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^g INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^h INSTITUT PASTEUR   (France)

Author keywords

Africa; Antimicrobial resistance; CG15; CG258; CTX M 15; Epidemiology; Extended spectrum lactamase; Klebsiella pneumoniae; Multilocus sequence typing; Vietnam

Indexed keywords

AMOXICILLIN; CEFALOTIN; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; TICARCILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CAMEROON; CLONAL VARIATION; CONTROLLED STUDY; DEVELOPING COUNTRY; ENTEROBACTERIALES; GENE SEQUENCE; GENETIC VARIABILITY; KLEBSIELLA PNEUMONIAE; MADAGASCAR; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PATIENT CARE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENEGAL; VIET NAM;

ENTEROBACTERIACEAE; KLEBSIELLA PNEUMONIAE;

EID: 84875485257     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2012.03805.x     Document Type: Article

References (30)

1. Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol 2010; 300: 371-379.
2. Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 2011; 35: 736-755.
3. Elhani D, Bakir L, Aouni M et al. Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia, 1999-2005. Clin Microbiol Infect 2010; 16: 157-164.
4. Lee MY, Ko KS, Kang CI, Chung DR, Peck KR, Song JH. High prevalence of CTX-M-15-producing Klebsiella pneumoniae isolates in Asian countries: diverse clones and clonal dissemination. Int J Antimicrob Agents 2011; 38: 160-163.
5. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005; 43: 4178-4182.
6. Guessennd N, Bremont S, Gbonon V et al. qnr-type quinolone resistance in extended-spectrum β-lactamase producing enterobacteria in Abidjan, Ivory Coast. Pathol Biol 2008; 56: 439-446.
7. Arlet G, Rouveau M, Philippon A. Substitution of alanine for aspartate at position 179 in the shv-6 extended-spectrum β-lactamase. FEMS Microbiol Lett 1997; 152: 163-167.
8. Yamane K, Wachino J, Suzuki S, Arakawa Y. Plasmid-mediated qepa gene among Escherichia coli clinical isolates from Japan. Antimicrob Agents Chemother 2008; 52: 1564-1566.
9. Zhou TL, Chen XJ, Zhou MM, Zhao YJ, Luo XH, Bao QY. Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolates in Wenzhou, Southern China, 2002-2008. Jpn J Infect Dis 2011; 64: 55-57.
10. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac(6')-ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2006; 50: 3953-3955.
11. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated Ampcβ-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 2153-2162.
12. Brisse S, Fevre C, Passet V et al. Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One 2009; 4: e4982.
13. Turner KM, Hanage WP, Fraser C, Connor TR, Spratt BG. Assessing the reliability of eburst using simulated populations with known ancestry. BMC Microbiol 2007; 7: 30.
14. Damjanova I, Toth A, Paszti J et al. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type β-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005 - the new 'MRSAs'?J Antimicrob Chemother 2008; 62: 978-985.
15. Nielsen JB, Skov MN, Jorgensen RL, Heltberg O, Hansen DS, Schonning K. Identification of CTX-M15-, SHV-28-producing Klebsiella pneumoniae ST15 as an epidemic clone in the Copenhagen area using a semi-automated REP-PCR typing assay. Eur J Clin Microbiol Infect Dis 2011; 30: 773-778.
16. Kitchel B, Rasheed JK, Patel JB et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 2009; 53: 3365-3370.
17. Samuelsen O, Naseer U, Tofteland S et al. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden. J Antimicrob Chemother 2009; 63: 654-658.
18. Ko KS, Lee JY, Baek JY et al. Predominance of an ST11 extended-spectrum β-lactamase-producing Klebsiella pneumoniae clone causing bacteraemia and urinary tract infections in Korea. J Med Microbiol 2010; 59: 822-828.
19. kpc-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids among Enterobacteriaceae species in Brazil. Antimicrob Agents Chemother 2011; 55: 3579-3583.
20. Decré D, Verdet C, Emirian A et al. Emerging severe and fatal infections due to Klebsiella pneumoniae in 2 French university hospitals. J Clin Microbiol 2011; 49: 3012-3014.
21. Turton JF, Englender H, Gabriel SN, Turton SE, Kaufmann ME, Pitt TL. Genetically similar isolates of Klebsiella pneumoniae serotype k1 causing liver abscesses in three continents. J Med Microbiol 2007; 56: 593-597.
22. Cao V, Lambert T, Nhu DQ et al. Distribution of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob Agents Chemother 2002; 46: 3739-3743.
23. Sire JM, Nabeth P, Perrier-Gros-Claude JD et al. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal. J Infect Dev Ctries 2007; 1: 263-268.
24. Bercion R, Mossoro-Kpinde D, Manirakiza A, Le Faou A. Increasing prevalence of antimicrobial resistance among Enterobacteriaceae uropathogens in Bangui, Central African Republic. J Infect Dev Ctries 2009; 3: 187-190.
25. Moyo SJ, Aboud S, Kasubi M, Lyamuya EF, Maselle SY. Antimicrobial resistance among producers and non-producers of extended spectrum β-lactamases in urinary isolates at a tertiary hospital in Tanzania. BMC Res Notes 2010; 3: 348.
26. Kothari A, Sagar V. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study. J Infect Dev Ctries 2008; 2: 354-358.
27. Ruppe E, Hem S, Lath S et al. CTX-M β-lactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia. Emerg Infect Dis 2009; 15: 741-748.
28. Moquet O, Bouchiat C, Kinana A et al. Class D OXA-48 carbapenemase in multidrug-resistant enterobacteria, Senegal. Emerg Infect Dis 2011; 17: 143-144.
29. Breurec S, Fall C, Pouillot R et al. Epidemiology of methicillin-susceptible Staphylococcus aureus lineages in five major African towns: high prevalence of Panton-Valentine leukocidin genes. Clin Microbiol Infect 2011; 17: 633-639.
30. Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2011; 10: 597-602.